Clinical Interests: Medical Genetics, Pediatric Genetics, Inborn Errors of Metabolism, Lysosomal Storage Diseases, Newborn Screening, Urea Cycle Disorders, Hyperammonemia, Fatty Acid Oxidation Defects, Organic Acidemias, Maple Syrup Urine Disease
Dr. Wasserstein is the Director of the Program for Inherited Metabolic Diseases (PIMD) at Mount Sinai Medical Center. This program is one of the largest metabolic disease treatment programs in the country, treating several hundred patients who are diagnosed with rare inborn errors of metabolism. The PIMD is a New York State Newborn Screening designated referral center for infants with inherited metabolic diseases, and is also the leading referral center in the region for the evaluation of patients with suspected inborn errors of metabolism. Disorders that are treated at the PIMD include:
Dr. Wasserstein is part of Mount Sinai's International Center for Types A and B Niemann-Pick disease. She is also a clinical researcher, focusing on evaluating the safety and effectiveness of novel treatments for patients with inborn errors of metabolism.
In the News: Dr. Wasserstein discusses testing babies for metabolic disorders in the The Daily News feature, The Daily Check Up.
Wasserstein MP, Buchsbaum MS, Sansaricq C, Snyderman SE. Cerebral glucose metabolism in patients with early treated classical phenylketonuria. Molec Genet Metab 2006 March; 87: 272-277.
Wasserstein MP, Desnick RJ, Schuchman EH, McGovern MM, Wallenstein S, Lamm C, Hossain S. Natural history of type B Niemann-Pick Disease: results from a ten. Pediatrics 2004 Dec; 114(6): 672-677.
Salomons GS, Gibson KM, Landegge Pope L, Errami A, Potter M, Nowaczyk M, Olpin S, Manning N, Raiman JJ, Slade T, Champion MP, Peck D, Gavrilov D, Hillman R, Hoganson GE, Donaldson K, Shield JH, Ketteridge D, Wasserstein MP, Jakobs C. Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency. J Inherit Metab Dis 2007 Feb; 30(1): 23-28.
McGovern MM, Aron A, Wasserstein MP, Desnick RJ, Brodie SE. Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology 2006 Jan 24; 66(2): 228-232.
Willis A, Vanhuse C, Newton K, Wasserstein M, Morotti R. Farber Disease Type IV Presenting with Cholestatic Jaundice and neonatal liver failure:Report of Two Cases. Pediatr Dev Pathol 2007 Sept; 28(1).
Melissa P. Wasserstein, MD's contact info
Address & contact info:
Mount Sinai Doctors Faculty Practice
1428 Madison Avenue
1st Floor, Room Ab1-12
New York, NY 10029 Phone: 212-241-6947
Every effort has been made to ensure the accuracy of the information in this directory. However some
changes may occur between updates. Please check with your provider to ensure that he or she
participates in your health plan.
Last Updated: February 13th, 2012
Sharecare News posted a story about Genetic Medicine:
THURSDAY, April 17, 2014 (HealthDay News) -- Researchers who sequenced the genome of a deadly fungus say their achievement offers a genetic map for finding weaknesses in the fungus in order to fight it.
Cryptococcus neoformans causes millions of cases of pneumonia and meningitis e...Full Article
MONDAY, April 14, 2014 (HealthDay News) -- A new study found that 10 percent of women with a personal or family history of breast or other cancers had at least one gene mutation that would lead their doctors to recommend changes in their routine care, including increased cancer screening.
Sharecare News posted a story about Endocrinology/diabetes/metabolism:
TUESDAY, April 1, 2014 (HealthDay News) -- A new gene mutation associated with amyotrophic lateral sclerosis -- also known as ALS or Lou Gehrig's disease -- has been identified in a study led by the U.S National Institute on Aging (NIA).
ALS is a fatal degenerative condition that kills ne...Full Article
MONDAY, March 31, 2014 (HealthDay News) The drug Alprolix has been approved by the U.S. Food and Drug Administration as the first long-acting hemophilia B clotting agent, the FDA said in a news release.
The product, formally known as "coagulation factor IX recombinant Fc Fusion protein" ...Full Article
Sharecare News posted a story about Genetic Medicine:
WEDNESDAY, March 26, 2014 (HealthDay News) -- Scientists say they've constructed an "atlas" that maps the ways human genes are turned on and off, offering potentially important new insights into health and disease.
The new atlas builds on the achievements of the Human Genome Project -- th...Full Article
Sharecare News posted a story about Mental Health:
WEDNESDAY, March 5, 2014 (HealthDay News) -- In an early step toward drug-free HIV therapy, researchers are reporting the first success in genetically "editing" T-cells in patients' immune systems to become resistant to the virus.
The findings, published in the March 6 issue of the New...Full Article
THURSDAY, Feb. 27, 2014 (HealthDay News) -- There's early evidence from a small study that people with amyotrophic lateral sclerosis -- also known as ALS or Lou Gehrig's disease -- who are fed a high-calorie, high-carb diet, may see the progression of their disease slowed.
MONDAY, Feb. 24, 2014 (HealthDay News) -- Women who carry a BRCA1 gene mutation and have their ovaries removed by age 35 appear to dramatically reduce their odds of developing ovarian cancer and dying, a new international study finds.
Having this procedure, called oophorectomy, may reduce...Full Article